Health Events Local 2026-03-12T04:47:58+00:00

The Future of Medicine: Digital, Robotic, and Collaborative

The MIND 360 Summit in São Paulo brought together healthcare leaders to discuss the future of innovation in Latin America. Experts discussed how digitalization, personalized medicine, and device miniaturization are changing clinical practice, making treatment less invasive and more effective for patients.


From an expert perspective, three factors are shaping the evolution of contemporary medicine: the digitalization of health, personalized medicine, and the miniaturization of medical devices. The executive explained that advances in new materials and smaller, more precise technologies are enabling treatments to be less invasive, safer, and increasingly patient-centric. The future of medicine: digital, robotic, and collaborative. Discussions at MIND 360 also anticipate a profound transformation in how doctors are trained and how technologies are integrated into the clinical process. In this context, it was highlighted that Medtronic trains over 1,800 healthcare professionals each year in Latin America, particularly in Mexico, which represents a significant contribution to raising clinical standards in hospitals and health systems. Despite technological advances, the specialist acknowledged that the availability of medical innovation in Latin America faces structural challenges. In this scenario, Héctor Orellana, Vice President for Northern Latin America at the company, presented the trends that are redefining clinical practice in the region. In an exclusive interview with LaSalud.mx, the specialist emphasized that one of the main contributions of MIND 360 is the strategic conversation that is generated among health systems, industry, and medical professionals to analyze the pace of technological adoption in Latin America. Orellana pointed out that digitalization will enable new remote training modalities, advanced medical simulation, and tools for distance learning. Similarly, the miniaturization of devices, robotics, and digital platforms will be decisive factors in the next five years for improving diagnostics, treatments, and clinical outcomes. In conclusion, the executive thanked LaSalud.mx for their coverage and reiterated that Medtronic seeks to act as a facilitator within the healthcare ecosystem, collaborating with doctors and institutions so that technological innovation reaches more patients in Latin America. According to him, these spaces allow us to understand where medical innovation is heading and what conditions are necessary to accelerate its real implementation in the region's countries. For Orellana, the debate on innovation must focus on tangible clinical results and not just on technological narratives. Digitalization, miniaturization, and robotic surgery are beginning to redefine how patients are diagnosed and treated in the region's health systems. Another of the central points addressed during the meeting was the transfer of knowledge between regional markets, particularly between countries with complex health ecosystems like Brazil and Mexico. Orellana emphasized that continuous medical education is one of the main catalysts to accelerate technological adoption. Among them, he mentioned regulatory harmonization between countries and the optimization of resource use in health systems. For Orellana, technological adoption requires coordinated health ecosystems in which regulatory authorities, medical institutions, industry, and clinical professionals participate. The key — he explained — is not necessarily in having more resources, but in using them more efficiently to expand access to technologies that improve patient care.